SCHEMBL5146175

SCHEMBL5146175

O=C(O)CCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 3/20 0.62
HDAC1 Q13547 3/20 0.62
HDAC2 Q92769 3/20 0.62
HDAC8 Q9BY41 3/20 0.62
NCOR2 Q9Y618 2/20 0.62
KEAP1 Q14145 1/20 0.54
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
HTT P42858 1/20 0.50
MAPK1 P28482 1/20 0.50
ADRA1A P35348 1/20 0.50
HDAC4 P56524 1/20 0.50
SLC6A3 Q01959 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50
HDAC5 Q9UQL6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28989572 0.98 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC8NCOR2
Ammonia Solution, Strong SCHEMBL27489179 0.98 HDAC3 (0.60) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL801660 0.96 HDAC3 (0.57) HDAC3HDAC1HDAC2HDAC8NCOR2
Hydrochloric Acid SCHEMBL20875269 0.94 HDAC3 (0.56) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL13068773 0.89 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL11682230 0.89 BCHE (0.60) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL1830778 0.88 HDAC3 (0.63) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL10352451 0.87 RORC (0.58) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL21665226 0.87 HDAC8 (0.47) HDAC3HDAC1HDAC2HDAC8NCOR2
SCHEMBL6511657 0.87 HDAC3 (0.50) HDAC3HDAC1HDAC2HDAC8NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115996932-A New macrocyclic LRRK2 kinase inhibitors 法国施维雅药厂 2023-04-21 CN disclosed
EP-3890713-A1 L-DOPA AND/OR DOPA DECARBOXYLSE INHIBITORS CONJUGATED TO SUGAR FOR THE TREATMENT OF DOPAMINE-RESPONSIVE DISORDERS B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University (IL) 2021-10-13 EP disclosed
WO-2020115753-A1 L-DOPA AND/OR DOPA DECARBOXYLSE INHIBITORS CONJUGATED TO SUGAR FOR THE TREATMENT OF DOPAMINE-RESPONSIVE DISORDERS B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY (IL) 2020-06-11 WO disclosed
EP-1765348-A2 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES 3M Innovative Properties Company (US) 2007-03-28 EP disclosed
WO-2006028545-A2 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-03-16 WO disclosed
US-4990669-A Optically active α-amino aldehydes, process for the preparation thereof, and the use thereof for the stereoselective preparation of optically active β-amino alcohols BAYER AKTIENGESELLSCHAFT (DE) 1991-02-05 US disclosed